Insider Ledger
RTSN insider buying and SEC filings, explained
Retension Pharmaceuticals, Inc. · CIK 2002988
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$370K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 13, 2026 | Purchase (code P) | Eric L. Keller (CEO and Director) bought 20,800 shares at $12.00 ($250K), reported as a purchase (code P). Holdings up 5% to 423,377 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 13, 2026, 6:12 PM ET |
| Oct 13, 2026 | Purchase (code P) | Franklin M. Berger (Director) bought 10,000 shares indirectly at $12.00 ($120K), reported as a purchase (code P). New position of 10,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 13, 2026, 6:10 PM ET |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$370K in purchases since Oct 13, 2026 · Purchases traded Oct 13, 2026 to Oct 13, 2026 · Active
| Insider | Value | Traded | Source |
|---|---|---|---|
| Franklin M. Berger (Director) | $120K | Oct 13, 2026 | SEC filing |
| Eric L. Keller (CEO) | $250K | Oct 13, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RTSN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.